7 research outputs found
Signatures of Selection in the Genomes of Commercial and Non-Commercial Chicken Breeds
Identifying genomics regions that are affected by selection is important to understand the domestication and selection history of the domesticated chicken, as well as understanding molecular pathways underlying phenotypic traits and breeding goals. While whole-genome approaches, either high-density SNP chips or massively parallel sequencing, have been successfully applied to identify evidence for selective sweeps in chicken, it has been difficult to distinguish patterns of selection and stochastic and breed specific effects. Here we present a study to identify selective sweeps in a large number of chicken breeds (67 in total) using a high-density (58 K) SNP chip. We analyzed commercial chickens representing all major breeding goals. In addition, we analyzed non-commercial chicken diversity for almost all recognized traditional Dutch breeds and a selection of representative breeds from China. Based on their shared history or breeding goal we in silico grouped the breeds into 14 breed groups. We identified 396 chromosomal regions that show suggestive evidence of selection in at least one breed group with 26 of these regions showing strong evidence of selection. Of these 26 regions, 13 were previously described and 13 yield new candidate genes for performance traits in chicken. Our approach demonstrates the strength of including many different populations with similar, and breed groups with different selection histories to reduce stochastic effects based on single populations
Overexpression of Nell-1, a craniosynostosis-associated gene, induces apoptosis in osteoblasts during craniofacial development
Introduction: Craniosynostosis (CS), one of the most common congenital
craniofacial deformities, is the premature closure of cranial sutures.
Previously, we reported NELL-1 as a novel molecule overexpressed during
premature cranial suture closure in patients with CS. Nell-1
overexpression induced calvarial overgrowth and resulted in premature
suture closure in a rodent model. On a cellular level, Nell-1 is
suggested to promote osteoblast differentiation.
Materials and Methods: Different levels of Nell-1 were introduced into
osteoblastic cells by viral infection and recombinant protein. Apoptosis
and gene expression assays were performed. Mice overexpressing Nell-1
were examined for apoptosis.
Results: In this report, we further showed that overexpression of Nell-1
induced apoptosis along with modulation of apoptosis-related genes. The
induction of apoptosis by Nell-1 was observed only in osteoblastic cells
and not in NIH3T3 or primary fibroblasts. The CS mouse model
overexpressing Nell-1 showed increased levels of apoptosis in the
calvaria.
Conclusion: We show that Nell-1 expression modulates calvarial
osteoblast differentiation and apoptosis pathways. Nell-1 overexpression
disrupts these pathways resulting in craniofacial anomalies such as
premature suture closure
Novel Wnt Regulator NEL-Like Molecule-1 Antagonizes Adipogenesis and Augments Osteogenesis Induced by Bone Morphogenetic Protein 2
The differentiation factor NEL-like molecule-1 (NELL-1) has been reported as osteoinductive in multiple in vivo preclinical models. Bone morphogenetic protein (BMP)-2 is used clinically for skeletal repair, but in vivo administration can induce abnormal, adipose-filled, poor-quality bone. We demonstrate that NELL-1 combined with BMP2 significantly optimizes osteogenesis in a rodent femoral segmental defect model by minimizing the formation of BMP2-induced adipose-filled cystlike bone. In vitro studies using the mouse bone marrow stromal cell line M2-10B4 and human primary bone marrow stromal cells have confirmed that NELL-1 enhances BMP2-induced osteogenesis and inhibits BMP2-induced adipogenesis. Importantly, the ability of NELL-1 to direct BMP2-treated cells toward osteogenesis and away from adipogenesis requires intact canonical Wnt signaling. Overall, these studies establish the feasibility of combining NELL-1 with BMP2 to improve clinical bone regeneration and provide mechanistic insight into canonical Wnt pathway activity during NELL-1 and BMP2 osteogenesis. The novel abilities of NELL-1 to stimulate Wnt signaling and to repress adipogenesis may highlight new treatment approaches for bone loss in osteoporosis